0.761
0.01 (1.55%)
| Penutupan Terdahulu | 0.749 |
| Buka | 0.745 |
| Jumlah Dagangan | 385,372 |
| Purata Dagangan (3B) | 6,573,455 |
| Modal Pasaran | 33,925,124 |
| Harga / Jualan (P/S) | 0.380 |
| Harga / Buku (P/B) | 2.40 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -63.52% |
| Margin Operasi (TTM) | -7.46% |
| EPS Cair (TTM) | -1.31 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -11.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 300.69% |
| Nisbah Semasa (MRQ) | 0.810 |
| Aliran Tunai Operasi (OCF TTM) | 3.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 5.51 M |
| Pulangan Atas Aset (ROA TTM) | -2.38% |
| Pulangan Atas Ekuiti (ROE TTM) | -138.80% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Harvard Bioscience, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.25 |
|
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 8.27% |
| % Dimiliki oleh Institusi | 69.66% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Williams & Novak, Llc | 30 Sep 2025 | 275,500 |
| Pasadena Private Wealth, Llc | 30 Sep 2025 | 243,911 |
| Julat 52 Minggu | ||
| Median | 2.00 (162.81%) | |
| Jumlah | 1 Tidak Dinilai | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Benchmark | 10 Sep 2025 | 2.00 (162.81%) | Tidak Dinilai | 0.450 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 06 Nov 2025 | Pengumuman | Harvard Bioscience Announces Third Quarter 2025 Financial Results |
| 30 Oct 2025 | Pengumuman | Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET |
| 16 Sep 2025 | Pengumuman | Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States |
| 09 Sep 2025 | Pengumuman | Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |